OncoDaily Newsletter
Subscribe to our newsletter
“Maybe the Best Thing That Happened Is That Didn’t Work Out”: Alan Sandler on Daraxonrasib
Key Insights from ASCO Breakthrough 2026 with Julie Gralow
What Really Killed Napoleon? The Autopsy Evidence Behind His Gastric Cancer Diagnosis
Radiotherapy in Sudan: Cancer Care Under Pressure From Infrastructure Gaps and Armed Conflict
Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits
FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC
25 Posts Not To Miss from MASCC 2026
Cancer Survivors on How Immunotherapy Saved Their Lives and the Critical Need for Research Funding
